Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 41

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Co-medications That Modulate Liver Injury and Repair Influence Clinical Outcome of Acetaminophen-Associated Liver Injury

Suzuki, Ayako, Yuen, Nancy, Walsh, John, Papay, Julie, Hunt, Christine M., Diehl, Anna Mae · 2009 · Clinical Gastroenterology and Hepatology

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cgh.2009.03.034

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 43

  1. Lee, 2007, Acetaminophen toxicity: changing perceptions on a social/medical issue, Hepatology, 46, 966, 10.1002/hep.21926 · DOI
  2. Schiodt, 1999, Etiology and outcome for 295 patients with acute liver failure in the United States, Liver Transpl Surg, 5, 29, 10.1002/lt.500050102 · DOI · Paper page
  3. Whitcomb, 1994, Association of acetaminophen hepatotoxicity with fasting and ethanol use, JAMA, 272, 1845, 10.1001/jama.1994.03520230055038 · DOI · Paper page
  4. Kuffner, 2001, Effect of maximal daily doses of acetaminophen on the liver of alcoholic patients: a randomized, double-blind, placebo-controlled trial, Arch Intern Med, 161, 2247, 10.1001/archinte.161.18.2247 · DOI
  5. Larson, 2005, Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study, Hepatology, 42, 1364, 10.1002/hep.20948 · DOI · Paper page
  6. Myers, 2008, Impact of liver disease, alcohol abuse, and unintentional ingestions on the outcomes of acetaminophen overdose, Clin Gastroenterol Hepatol, 6, 918, 10.1016/j.cgh.2008.02.053 · DOI
  7. Schmidt, 2002, Acute versus chronic alcohol consumption in acetaminophen-induced hepatotoxicity, Hepatology, 35, 876, 10.1053/jhep.2002.32148 · DOI · Paper page
  8. Mehendale, 2005, Tissue repair: an important determinant of final outcome of toxicant-induced injury, Toxicol Pathol, 33, 41, 10.1080/01926230590881808 · DOI · Paper page
  9. Cai, 2000, Lovastatin decreases mortality and improves liver functions in fulminant hepatic failure from 90% partial hepatectomy in rats, J Hepatol, 32, 67, 10.1016/S0168-8278(00)80191-9 · DOI
  10. Demirbilek, 2007, Fluvastatin reduced liver injury in rat model of extrahepatic cholestasis, Pediatr Surg Int, 23, 155, 10.1007/s00383-006-1829-y · DOI
  11. Lai, 2008, Pharmacological preconditioning with simvastatin protects liver from ischemia-reperfusion injury by heme oxygenase-1 induction, Transplantation, 85, 732, 10.1097/TP.0b013e3181664e70 · DOI
  12. Tokunaga, 2008, Beneficial effects of fluvastatin on liver microcirculation and regeneration after massive hepatectomy in rats, Dig Dis Sci, 53, 2989, 10.1007/s10620-008-0241-y · DOI
  13. Ramalho, 2002, Effect of angiotensin-converting enzyme inhibitors on liver regeneration in rats, Hepatogastroenterology, 49, 1347
  14. Yayama, 2007, Angiotensin-converting enzyme inhibitor enhances liver regeneration following partial hepatectomy: involvement of bradykinin B2 and angiotensin AT1 receptors, Biol Pharm Bull, 30, 591, 10.1248/bpb.30.591 · DOI
  15. Clement, 2005, Protection against paracetamol-induced hepatic injury by prazosin pre-treatment in CD-1 mice, Mutat Res, 579, 182, 10.1016/j.mrfmmm.2005.03.028 · doi:10.1016/j.mrfmmm.2005.03.028
  16. Oben, 2003, Sympathetic nervous system inhibition increases hepatic progenitors and reduces liver injury, Hepatology, 38, 664, 10.1053/jhep.2003.50371 · DOI
  17. Reyes-Salcido, 2003, Evidence that dl-propranolol increases thymidine kinase activity, cell mitosis, and beta-adrenoceptors during rat liver regeneration, Arch Med Res, 34, 273, 10.1016/S0188-4409(03)00049-3 · doi:10.1016/s0188-4409(03)00049-3
  18. Ronsein, 2005, Cytoprotective effects of carvedilol against oxygen free radical generation in rat liver, Redox Rep, 10, 131, 10.1179/135100005X38879 · DOI
  19. Donthamsetty, 2008, Nonalcoholic steatohepatitic (NASH) mice are protected from higher hepatotoxicity of acetaminophen upon induction of PPARalpha with clofibrate, Toxicol Appl Pharmacol, 230, 327, 10.1016/j.taap.2008.02.031 · DOI
  20. Mehendale, 2000, PPAR-alpha: a key to the mechanism of hepatoprotection by clofibrate, Toxicol Sci, 57, 187, 10.1093/toxsci/57.2.187 · DOI
  21. Nicholls-Grzemski, 1992, Peroxisome proliferators protect against paracetamol hepatotoxicity in mice, Biochem Pharmacol, 43, 1395, 10.1016/0006-2952(92)90193-M · DOI
  22. James, 1993, Phenylpropanolamine potentiation of acetaminophen-induced hepatotoxicity: evidence for a glutathione-dependent mechanism, Toxicol Appl Pharmacol, 118, 159, 10.1006/taap.1993.1021 · doi:10.1006/taap.1993.1021
  23. Roberts, 1994, Methylphenidate-induced hepatotoxicity in mice and its potentiation by beta-adrenergic agonist drugs, Life Sci, 55, 269, 10.1016/0024-3205(94)00729-2 · doi:10.1016/0024-3205(94)00729-2
  24. Roberts, 1991, Potentiation of carbon tetrachloride hepatotoxicity by phenylpropanolamine, Toxicol Appl Pharmacol, 111, 175, 10.1016/0041-008X(91)90022-7 · doi:10.1016/0041-008x(91)90022-7
  25. Oben, 2004, Sympathetic nervous system regulation of liver repair, Anat Rec A Discov Mol Cell Evol Biol, 280, 874, 10.1002/ar.a.20081 · DOI
  26. Grypioti, 2008, Platelet activating factor (PAF) antagonism with ginkgolide B protects the liver against acute injury, Dig Dis Sci, 53, 1054, 10.1007/s10620-007-9982-2 · DOI
  27. Nocito, 2007, Platelets and platelet-derived serotonin promote tissue repair after normothermic hepatic ischemia in mice, Hepatology, 45, 369, 10.1002/hep.21516 · DOI · Paper page
  28. Maurer-Spurej, 2004, The influence of selective serotonin reuptake inhibitors on human platelet serotonin, Thromb Haemost, 91, 119, 10.1160/TH03-05-0330 · DOI · Paper page
  29. Begay, 2003, Late administration of COX-2 inhibitors minimize hepatic necrosis in chloroform induced liver injury, Toxicology, 185, 79, 10.1016/S0300-483X(02)00594-2 · doi:10.1016/s0300-483x(02)00594-2
  30. Beraza, 2005, Interplay among cardiotrophin-1, prostaglandins, and vascular endothelial growth factor in rat liver regeneration, Hepatology, 41, 460, 10.1002/hep.20590 · DOI
  31. Ito, 2003, Effects of selective cyclooxygenase inhibitors on ischemia/reperfusion-induced hepatic microcirculatory dysfunction in mice, Eur Surg Res, 35, 408, 10.1159/000072174 · DOI
  32. Lesurtel, 2006, Platelet-derived serotonin mediates liver regeneration, Science, 312, 104, 10.1126/science.1123842 · DOI · Paper page
  33. Lammert, 2008, Relationship between daily dose of oral medications and idiosyncratic drug-induced liver injury: search for signals, Hepatology, 47, 2003, 10.1002/hep.22272 · DOI · Paper page
  34. Norata, 2003, Statins and oxidative stress during atherogenesis, J Cardiovasc Risk, 10, 181, 10.1097/00043798-200306000-00005 · doi:10.1097/00043798-200306000-00005
  35. Aviram, 1998, Atorvastatin and gemfibrozil metabolites, but not the parent drugs, are potent antioxidants against lipoprotein oxidation, Atherosclerosis, 138, 271, 10.1016/S0021-9150(98)00032-X · DOI · Paper page
  36. Lee, 2006, Inhibitory effect of luteolin on hepatocyte growth factor/scatter factor-induced HepG2 cell invasion involving both MAPK/ERKs and PI3K-Akt pathways, Chem Biol Interact, 160, 123, 10.1016/j.cbi.2006.01.002 · DOI
  37. Hsieh, 2004, Akt/PKB and p38 MAPK signaling, translational initiation and longevity in Snell dwarf mouse livers, Mech Ageing Dev, 125, 785, 10.1016/j.mad.2004.07.008 · DOI · Paper page
  38. Mohr, 2008, Transgenic overexpression of insulin receptor substrate 1 in hepatocytes enhances hepatocellular proliferation in young mice only, Hepatol Res, 38, 1233, 10.1111/j.1872-034X.2008.00396.x · doi:10.1111/j.1872-034x.2008.00396.x
  39. Sonntag, 1992, Effects of aging and dietary restriction on tissue protein synthesis: relationship to plasma insulin-like growth factor-1, J Gerontol, 47, B159, 10.1093/geronj/47.5.B159 · DOI
  40. Yokoyama, 2007, Which gender is better positioned in the process of liver surgery?, Surg Today, 37, 823, 10.1007/s00595-007-3508-6 · DOI
  41. Jalouli, 2003, Sex difference in hepatic peroxisome proliferator-activated receptor alpha expression: influence of pituitary and gonadal hormones, Endocrinology, 144, 101, 10.1210/en.2002-220630 · DOI
  42. Studer, 1982, Differences between male and female rats in the regulation of hepatic glycogenolysis, J Biol Chem, 257, 7987, 10.1016/S0021-9258(18)34286-8 · DOI
  43. Rong, 2008, An aqueous extract of Salacia oblonga root, a herb-derived peroxisome proliferator-activated receptor-alpha activator, by oral gavage over 28 days induces gender-dependent hepatic hypertrophy in rats, Food Chem Toxicol, 46, 2165, 10.1016/j.fct.2008.02.022 · DOI

Cited by

See all 41

Metadata

Authors
Suzuki, A., Yuen, N., Walsh, J., Papay, J., Hunt, C. M., & Diehl, A. M.
Venue
Clinical Gastroenterology and Hepatology
Publisher
Elsevier BV
Published
2009-08
Volume
7
Issue
8
Pages
882-888
ISSN
1542-3565
Cited by
41
References
2
Language
en
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Co-medications That Modulate Liver Injury and Repair Influence Clinical Outcome of Acetaminophen-Associated Liver Injury. https://app.cochat.ai/papers/10.1016/j.cgh.2009.03.034
The paper
Suzuki, A., Yuen, N., Walsh, J., Papay, J., Hunt, C. M., & Diehl, A. M. (2009). Co-medications That Modulate Liver Injury and Repair Influence Clinical Outcome of Acetaminophen-Associated Liver Injury. Clinical Gastroenterology and Hepatology. https://doi.org/10.1016/j.cgh.2009.03.034

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.